Male Infertility Market Size, Share, Statistics, Trend Analysis and Forecast Report, 2020 - 2027

Global Male Infertility by Techniques (DNA Fragmentation Technique, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Penetration Assay, Oxidative Stress Analysis, Sperm Agglutination, and Others) By Region (North America, Europe, APAC, MEA, and Latin America)

  • Report ID : MD1322
  • |
  • Pages : 225
  • |
  • Tables : 84
  • |
  • Formats :

Male Infertility Market revenue is estimated to be $USD Billion in 2018 and shall grow with a CAGR of XX.X% the forecast period of 2018 to 2026.

global male infertility market
Infertility in males is characterized by numerous infertility associated problems such as the presence of low motile sperm, and low sperm count. A variety of causes for male infertility comprises the consumption of drugs or alcohol, stress, obesity, environmental toxins, smoking, among others, this reason acts as driving factors of the male infertility market. When a person is diagnosed with infertility, the individual undergoes enormous stress, guilt, and embarrassment that would further intensify the infertility problem. This is a major limitation of this market growth. The use of fertility treatment options by same-sex couples and single parents is expected to generate lucrative growth opportunities for the market in the forecast period. The Asia Pacific is anticipated to grow at the highest rate owing to increasing awareness, and rising incidence of infertility in men due to changes in the standard of living.


SEGMENT ANALYSIS

Techniques and geography is the segment considered in the male infertility market. Based on techniques, the market is divided into DNA fragmentation technique, computer-assisted semen analysis, microscopic examination, sperm penetration assay, oxidative stress analysis, sperm agglutination, and others.


MARKET PLAYER ANALYSIS

Major key players analyzed in this report are Access Pharmaceuticals, Pantarhei Bioscience B, SCSA diagnostics, ZydusCadila Healthcare Limited, ASKA Pharmaceutical Co. Ltd., Inc., Intas Pharmaceuticals Ltd., Cordex Pharma, Inc., Andrology Solutions, Merck Serono, and Halotech DNA SL, among others. The top global leaders in the industry of male infertility are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific, Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, Irvine Scientific, The Baker Company Inc., Kitazato, Rocket Medical Plc, IHMedical A/S, Hamilton Throne Ltd., MedGyn Products Inc., ZEISS Group, and SoMATEX Medical Technologies GmbH. These companies are mainly based in Europe and Asia Pacific. The multinational group of Cooper Companies is a major shareholder in the market. It has been dominating over all other companies since 2018. Following the Cooper Companies, comes the secong largest dominating company world-wide, Cook Group Incorporate which has been holding almost 40% of the shares in the market since 2017. There is an increasing demand in the male infertility market in the regions of North America and Africa. The companies are moving their businesses towards these regions to have a potential growth in the business. Many other companies such as Vitrolife AB, Thermo Fisher Scientific Inc. and Esco Micro are constantly releasing new plans and products to compete with the largest fertility companies in the world. Other industries in this domain that are growing at a high CAGR include Global Personal Care Appliances Market and Vitamin E Market.

 

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2020 – 2027)
• Data breakdown for every market segment (2020 – 2027)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown
Technology Analysis (Revenue, USD Million, 2020 - 2027)
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Penetration Assay
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Others
Region Analysis (Revenue, USD Million, 2020 - 2027)
• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• Middle East
• Japan
• Africa
• Rest of World

Male Infertility Market Companies
• EMD Serono, Inc.
• Endo International plc.
• Sanofi
• Bayer Group
• SCSA Diagnostics
• Andrology Solutions
• Halotech DNA SL
• Intas Pharmaceuticals Ltd.
• Aytu BioScience, Inc.
• Cadila Pharmaceuticals
• Vitrolife

Available Versions:-
United States Male Infertility Market Industry Research Report
Europe Male Infertility Market Industry Research Report
Asia Pacific Male Infertility Market Industry Research Report

CHAPTER 1:  INTRODUCTION

1.1. Research Methodology

1.1.1. Desk Research

1.1.2. Data Synthesis

1.1.3. Data Validation & Market Feedback

1.1.4. Data Sources

CHAPTER 2:  EXECUTIVE SUMMARY

2.1. Global Market Outlook

2.2. Core Insights - Techniques

2.3. Core Insights – Geography

CHAPTER 3:  MARKET OVERVIEW

3.1.  Market Definition and Scope

3.2. Key Forces Shaping the Industry

3.2.1. Bargaining Power of Suppliers

3.2.2. Bargaining Power of Buyers

3.2.3. Threat of Substitutes

3.2.4. Threat of New Entrants

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Supply-side Drivers

3.3.1.2. Demand-side Drivers

3.3.2. Restraints

3.3.3. Opportunities

3.4. Industry Landscape - PESTEL Analysis

3.4.1. Political Landscape

3.4.2. Environmental Landscape

3.4.3. Social Landscape

3.4.4. Technology Landscape

3.4.5. Economic Landscape

CHAPTER 4:  MARKET BACKGROUND

4.1. Industry Value Chain Analysis

4.1.1. Upstream Participants

4.1.2. Downstream participants

4.2. Pricing Analysis and Forecast, 2018-2026

4.2.1. By Type

4.2.2. By Region

CHAPTER 5:  GLOBAL MALE INFERTILITY MARKET, BY TECHNIQUES

5.1. Overview

5.1.1. Market Volume and Forecast, 2018-2026

5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

5.2. DNA Fragmentation Technique

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Volume and Forecast, By Region

5.2.3. Market Revenue (US$ Million) and Forecast, By Region

5.3. Computer Assisted Semen Analysis

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Volume and Forecast, By Region

5.3.3. Market Revenue (US$ Million) and Forecast, By Region

5.4. Microscopic Examination

5.4.1. Key Market Trends, Growth Factors and Opportunities

5.4.2. Market Volume and Forecast, By Region

5.4.3. Market Revenue (US$ Million) and Forecast, By Region

5.5. Sperm Penetration Assay

5.5.1. Key Market Trends, Growth Factors and Opportunities

5.5.2. Market Volume and Forecast, By Region

5.5.3. Market Revenue (US$ Million) and Forecast, By Region

5.6. Oxidative Stress Analysis

5.6.1. Key Market Trends, Growth Factors and Opportunities

5.6.2. Market Volume and Forecast, By Region

5.6.3. Market Revenue (US$ Million) and Forecast, By Region

5.7. Sperm Agglutination

5.7.1. Key Market Trends, Growth Factors and Opportunities

5.7.2. Market Volume and Forecast, By Region

5.7.3. Market Revenue (US$ Million) and Forecast, By Region

5.8. Others

5.8.1. Key Market Trends, Growth Factors and Opportunities

5.8.2. Market Volume and Forecast, By Region

5.8.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 6:  GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY

6.1. Overview

6.2. North America

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Volume and Forecast, By Techniques

6.2.3. Market Revenue and Forecast, By Techniques

6.2.4. Market Revenue and Forecast, By Country

6.2.5. U.S.

6.2.5.1. Market Volume and Forecast

6.2.5.2. Market Revenue and Forecast

6.2.6. Canada

6.2.6.1. Market Volume and Forecast

6.2.6.2. Market Revenue and Forecast

6.2.7. Mexico

6.2.7.1. Market Volume and Forecast

6.2.7.2. Market Revenue and Forecast

6.3. Europe

6.3.1. Market Volume and Forecast, By Techniques

6.3.2. Market Revenue and Forecast, By Techniques

6.3.3. Market Revenue and Forecast, By Country

6.3.4. Germany

6.3.4.1. Market Volume and Forecast, By Techniques

6.3.5. UK

6.3.5.1. Market Volume and Forecast, By Techniques

6.3.6. France

6.3.6.1. Market Volume and Forecast, By Techniques

6.3.7. Italy

6.3.7.1. Market Volume and Forecast, By Techniques

6.3.8. Rest of Europe

6.3.8.1. Market Volume and Forecast, By Techniques

6.4. Asia-Pacific

6.4.1. Market Volume and Forecast, By Techniques

6.4.2. Market Revenue and Forecast, By Techniques

6.4.3. Market Revenue and Forecast, By Country

6.4.4. China

6.4.4.1. Market Volume and Forecast, By Techniques

6.4.5. India

6.4.5.1. Market Volume and Forecast, By Techniques

6.4.6. Japan

6.4.6.1. Market Volume and Forecast, By Techniques

6.4.7. South Korea

6.4.7.1. Market Volume and Forecast, By Techniques

6.4.8. Rest of Asia-Pacific

6.4.8.1. Market Volume and Forecast, By Techniques

6.5. REST OF THE WORLD

6.5.1. Market Volume and Forecast, By Techniques

6.5.2. Market Revenue and Forecast, By Techniques

6.5.3. Market Revenue and Forecast, By Country

6.5.4. Latin America

6.5.4.1. Market Volume and Forecast, By Techniques

6.5.5. Middle East

6.5.5.1. Market Volume and Forecast, By Techniques

6.5.6. Africa

6.5.6.1. Market Volume and Forecast, By Techniques

CHAPTER 7:  COMPETITIVE LANDSCAPE

7.1. Male Infertility Market Share Analysis, 2018

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com